Search

Your search keyword '"Kirschner J"' showing total 2,298 results

Search Constraints

Start Over You searched for: Author "Kirschner J" Remove constraint Author: "Kirschner J"
2,298 results on '"Kirschner J"'

Search Results

1. STUDY PROTOCOL OF A MULTI-STAGE RANDOMISED CONTROLLED STUDY FOR THE ASSESSMENT OF POSTOPERATIVE THERAPEUTIC PROCEDURES AFTER TOTAL KNEE ARTHROPLASTY

3. Fine-tuning of canted magnetization in stepped Fe films through thickness variation, Au capping, and quantum confinement

4. Fine-tuning of canted magnetization in stepped Fe films through thickness variation, Au capping, and quantum confinement

5. Temperature Dependence of Magnetic Excitations: Terahertz Magnons above the Curie Temperature

6. Three dimensional boundary displacement due to stable ideal kink modes excited by external n=2 magnetic perturbations

7. Asymmetric Spin-wave Dispersion on Fe(110): Direct Evidence of Dzyaloshinskii--Moriya Interaction

8. The role of electron confinement in Pd films for the oscillatory magnetic anisotropy in an adjacent Co layer

10. Ferromagnetism of Pd(001) substrate induced by Antiferromagnetic CoO

12. Canted stripe phase evolution due to a spin reorientation transition in Fe films grown on Ag(001) vicinal surface

13. P196 Age at loss of ambulation in patients with DMD from the STRIDE registry and the CINRG natural history study: a matched cohort analysis

14. P198 Updated demographics and safety data from patients with nonsense mutation Duchenne muscular dystrophy receiving ataluren in the STRIDE registry

15. P230 Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)

16. P197 Pulmonary function in patients with Duchenne muscular dystrophy from the STRIDE registry and CINRG natural history study: a matched cohort analysis

17. The Multiple Sclerosis Inventory of Cognition for Adolescents (MUSICADO): A brief screening instrument to assess cognitive dysfunction, fatigue and loss of health-related quality of life in pediatric-onset multiple sclerosis

19. Huge magneto-crystalline anisotropy of x-ray linear dichroism observed on Co/FeMn bilayers

20. Three-dimensional magnetic flux-closure patterns in mesoscopic Fe islands

22. Effect of hydrogen on the atomic structure of Pd(001)

23. Angular-dependence of magnetization switching for a multi-domain dot: experiment and simulation

27. Characterization of pulmonary function in 10–18 year old patients with Duchenne muscular dystrophy

28. Real-World Data on the Efficacy of Gene Replacement Therapy for Spinal Muscular Atrophy (SMA).

29. Ocular Myasthenia: It's Worth a Second Look.

31. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy

35. P.113 Safety update: Risdiplam clinical trial development program

36. P.110 JEWELFISH: 24-month safety and pharmacodynamic data in non-treatment-naïve patients with spinal muscular atrophy (SMA)

37. P.103 Onasemnogene abeparvovec (OA) treatment outcomes by patient weight at infusion: Initial findings from the RESTORE registry

38. VP.20 Cathepsin D as biomarker in CSF of nusinersen-treated patients with spinal muscular atrophy

39. P.35 Genetic newborn screening and digital technologies to accelerate rare disease diagnosis: The EU-IMI screen4Care project

40. P.122 Comparative safety and efficacy of different corticosteroid regimens in boys with Duchenne muscular dystrophy: results of a randomized controlled trial

41. VP.51 Impact of nusinersen on caregiver experience and health-related quality of life (HRQoL) when initiated in the presymptomatic stage of SMA in NURTURE

42. P.23 Pulmonary function in patients with Duchenne muscular dystrophy from the STRIDE Registry and CINRG Natural History Study: a matched cohort analysis

43. P.22 Age at loss of ambulation in patients with DMD from the STRIDE registry and the CINRG natural history study: A matched cohort analysis

44. P.19 Updated demographics and safety data from patients with nonsense mutation Duchenne muscular dystrophy receiving ataluren in the STRIDE Registry

46. P.114 SUNFISH parts 1 and 2: 3-year efficacy and safety of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)

47. P.104 Treatments and outcomes for patients with spinal muscular atrophy (SMA) type 2: Findings from RESTORE registry

48. P.105 Safety and effectiveness of onasemnogene abeparvovec (OA) alone or with other disease-modifying therapies (DMTs): Findings from RESTORE

49. Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study

Catalog

Books, media, physical & digital resources